666 related articles for article (PubMed ID: 34752810)
1. The anti-androgenic effect of quercetin on hyperandrogenism and ovarian dysfunction induced in a dehydroepiandrosterone rat model of polycystic ovary syndrome.
Mahmoud AA; Elfiky AM; Abo-Zeid FS
Steroids; 2022 Jan; 177():108936. PubMed ID: 34752810
[TBL] [Abstract][Full Text] [Related]
2. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study.
Furat Rencber S; Kurnaz Ozbek S; Eraldemır C; Sezer Z; Kum T; Ceylan S; Guzel E
J Ovarian Res; 2018 Jun; 11(1):55. PubMed ID: 29958542
[TBL] [Abstract][Full Text] [Related]
3. Quercetin modulates granulosa cell mRNA androgen receptor gene expression in dehydroepiandrosterone-induced polycystic ovary in Wistar rats via metabolic and hormonal pathways.
Olaniyan OT; Bamidele O; Adetunji CO; Priscilla B; Femi A; Ayobami D; Okotie G; Oluwaseun I; Olugbenga E; Mali PC
J Basic Clin Physiol Pharmacol; 2020 Mar; 31(4):. PubMed ID: 32160160
[TBL] [Abstract][Full Text] [Related]
4. The phytoestrogen, quercetin, in serum, uterus and ovary as a potential treatment for dehydroepiandrosterone-induced polycystic ovary syndrome in the rat.
Jafari Khorchani M; Zal F; Neisy A
Reprod Fertil Dev; 2020 Feb; 32(3):313-321. PubMed ID: 31661670
[TBL] [Abstract][Full Text] [Related]
5. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
[TBL] [Abstract][Full Text] [Related]
6. Dehydroepiandrosterone with a high-fat diet treatment at inducing polycystic ovary syndrome in rat model.
He Y; Li X; Li Y; Kuai D; Zhang H; Wang Y; Tian W
Steroids; 2024 Jun; 206():109424. PubMed ID: 38642598
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome.
Tessaro I; Modina SC; Franciosi F; Sivelli G; Terzaghi L; Lodde V; Luciano AM
J Ovarian Res; 2015 Oct; 8():64. PubMed ID: 26437930
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of quercetin on the improvement of ovulation disorder and regulation of ovarian CNP/NPR2 in PCOS model rats.
Zheng S; Chen Y; Ma M; Li M
J Formos Med Assoc; 2022 Jun; 121(6):1081-1092. PubMed ID: 34538551
[TBL] [Abstract][Full Text] [Related]
9. Apelin receptor modulation mitigates letrozole-induced polycystic ovarian pathogenesis in mice.
Anima B; Gurusubramanian G; Roy VK
Cytokine; 2024 Jul; 179():156639. PubMed ID: 38733946
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment with dehydroepiandrosterone may lead to follicular atresia through interaction with anti-Mullerian hormone.
Ikeda K; Baba T; Morishita M; Honnma H; Endo T; Kiya T; Saito T
J Ovarian Res; 2014; 7():46. PubMed ID: 24851135
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
[TBL] [Abstract][Full Text] [Related]
12. Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats.
Wu LM; Wang YX; Zhan Y; Liu AH; Wang YX; Shen HF; Wang YF; Wang LY; Tao ZB; Wang YQ
Peptides; 2021 Nov; 145():170624. PubMed ID: 34375684
[TBL] [Abstract][Full Text] [Related]
13. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome.
Abramovich D; Irusta G; Bas D; Cataldi NI; Parborell F; Tesone M
Endocrinology; 2012 Jul; 153(7):3446-56. PubMed ID: 22577112
[TBL] [Abstract][Full Text] [Related]
15. Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome.
Li Y; Zheng Q; Sun D; Cui X; Chen S; Bulbul A; Liu S; Yan Q
J Cell Physiol; 2019 May; 234(5):7435-7447. PubMed ID: 30580448
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of Kuntai Capsules in treatment of polycystic ovary syndrome rat models based on AGE-RAGE signal pathway].
Huang JG; Zhang J; Xiang RJ; Wu YY; He TY; Zhao MN; Wang F
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1082-1090. PubMed ID: 38621915
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of Bcl-2 and Bax in follicles within dehydroepiandrosterone-induced polycystic ovaries in rats.
Bas D; Abramovich D; Hernandez F; Tesone M
Cell Biol Int; 2011 May; 35(5):423-9. PubMed ID: 21062263
[TBL] [Abstract][Full Text] [Related]
18. Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology.
Krishnan A; Muthusami S; Periyasamy L; Stanley JA; Gopalakrishnan V; Ramachandran I
Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32120970
[No Abstract] [Full Text] [Related]
19. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
20. The ameliorative effects of marjoram in dehydroepiandrosterone induced polycystic ovary syndrome in rats.
Rababa'h AM; Matani BR; Ababneh MA
Life Sci; 2020 Nov; 261():118353. PubMed ID: 32877649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
